propranolol has been researched along with rilpivirine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Huang, L; Jiang, S; Lee, KH; Liu, N; Morris-Natschke, SL; Qin, B; Wei, L; Xie, L; Yu, F; Zheng, W; Zhu, DQ | 1 |
| Chen, CH; Huang, L; Lee, KH; Morris-Natschke, SL; Wang, HL; Wei, L; Xie, L | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
3 other study(ies) available for propranolol and rilpivirine
| Article | Year |
|---|---|
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines with High Potency against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus.
Topics: Aniline Compounds; Anti-HIV Agents; Drug Resistance, Viral; HIV-1; Mass Spectrometry; Models, Molecular; Mutation; Proton Magnetic Resonance Spectroscopy; Reverse Transcriptase Inhibitors; Rilpivirine | 2016 |
Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.
Topics: Aniline Compounds; Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Microbial Sensitivity Tests; Molecular Structure; Mutation; Reverse Transcriptase Inhibitors; Rilpivirine; Structure-Activity Relationship; Virus Replication | 2017 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |